These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 36045702
1. A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? Aimar G, Paratore C, Zichi C, Marino D, Sperti E, Caglio A, Gamba T, De Vita F, Di Maio M. Explor Target Antitumor Ther; 2021; 2(5):448-464. PubMed ID: 36045702 [Abstract] [Full Text] [Related]
5. Cell of origin in biliary tract cancers and clinical implications. Moeini A, Haber PK, Sia D. JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585 [Abstract] [Full Text] [Related]
6. Treating Biliary Tract Cancers: New Targets and Therapies. Ho J, Fiocco C, Spencer K. Drugs; 2022 Nov; 82(17):1629-1647. PubMed ID: 36441502 [Abstract] [Full Text] [Related]
12. Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study. Perkhofer L, Berger AW, Beutel AK, Gallmeier E, Angermeier S, Fischer von Weikersthal L, Goetze TO, Muche R, Seufferlein T, Ettrich TJ. BMC Cancer; 2019 Oct 23; 19(1):990. PubMed ID: 31646981 [Abstract] [Full Text] [Related]